CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale President & CEO sold 3,740 shares at an average $1.40 ($5,220)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 971 shares at an average $1.40 ($1,355)
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market buy Director bought 40,000 shares at $1.40 ($55,916)
- 4 Open-market buy Director bought 100,253 shares at $1.36 ($136,585)
- 4 Open-market buy Director bought 75,000 shares at $1.38 ($103,710)
- 4 Open-market buy Director bought 22,500 shares at $1.37 ($30,866)
- 4 Open-market buy Director bought 71,200 shares at an average $1.36 ($97,068)
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 8 of 31 · 602 filings